Skip to main content
Top
Published in: Indian Journal of Pediatrics 7/2020

01-07-2020 | Muscular Dystrophy | Editorial Commentary

Duchenne Muscular Dystrophy- Where Genetic Testing is Inevitable and Vital!

Authors: Ambika Gupta, Madhulika Kabra, Neerja Gupta

Published in: Indian Journal of Pediatrics | Issue 7/2020

Login to get access

Excerpt

Duchenne Muscular Dystrophy (DMD), an X-linked recessive disorder, is the most common and severe neuromuscular disorder affecting about 1 in 5000 males. The phenotype of dystrophinopathies depends on whether mutation leads to disruption of or maintenance of the “open reading frame (ORF)”, the former resulting in severe disease. The types of mutations in DMD include deletions (65%), duplications (6–10%), point mutations (25%), and complex mutations (<2%) [1]. Kohli S and colleagues have described a similar mutation spectrum of 1660 Indian DMD/ Becker muscular dystrophy (BMD) patients [2]. They identified exonic deletions and duplications in 1090 (65.7%) and 98 (5.9%) respectively. Among the 68 nondeletion/duplication cases tested, 50% had a nonsense mutation. …
Literature
4.
go back to reference Mendell JR, Goemans N, Lowes LP, et al. Eteplirsen Study Group and Telethon Foundation DMD Italian Network. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol. 2016;79:257–71.CrossRef Mendell JR, Goemans N, Lowes LP, et al. Eteplirsen Study Group and Telethon Foundation DMD Italian Network. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol. 2016;79:257–71.CrossRef
6.
go back to reference Waldrop MA, Flanigan KM. Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol. 2019;32:722–7.CrossRef Waldrop MA, Flanigan KM. Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol. 2019;32:722–7.CrossRef
7.
go back to reference Bladen CL, Salgado D, Monges S, et al. The TREAT-NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations. Hum Mutat. 2015;36:395–402.CrossRef Bladen CL, Salgado D, Monges S, et al. The TREAT-NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations. Hum Mutat. 2015;36:395–402.CrossRef
8.
go back to reference Ciafaloni E, Fox DJ, Pandya S, et al. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155:380–5.CrossRef Ciafaloni E, Fox DJ, Pandya S, et al. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155:380–5.CrossRef
9.
go back to reference Connolly AM, Zaidman CM, Golumbek PT, et al. MDA DMD Clinical Research Network. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019;59:650–7.CrossRef Connolly AM, Zaidman CM, Golumbek PT, et al. MDA DMD Clinical Research Network. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019;59:650–7.CrossRef
Metadata
Title
Duchenne Muscular Dystrophy- Where Genetic Testing is Inevitable and Vital!
Authors
Ambika Gupta
Madhulika Kabra
Neerja Gupta
Publication date
01-07-2020
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 7/2020
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-020-03324-w

Other articles of this Issue 7/2020

Indian Journal of Pediatrics 7/2020 Go to the issue